HRT breast cancer link in dispute again
This article was originally published in Scrip
The link between breast cancer risk and hormone replacement therapy (HRT) has been called into question again in an article published in the British Medical Journal's Journal of Family Planning and Reproductive Health Care. But some of the researchers who originally postulated the association argue that the latest publication only airs previously stated views, which have already been refuted, and they point to a large body of evidence for the causative link between HRT and breast cancer.
You may also be interested in...
INFOGRAPHIC: In 2019, 10 blockbuster medicines booked combined sales of $92.5bn. This infographic examines those drugs that commanded the greatest revenues globally, and answers some key questions. Which therapeutic areas include the most lucrative blockbusters? Which companies enjoyed their spoils? And which drugs were new to the top 10 last year? It also takes a look at the position of these products on the all-important US market.
Fundraising in the life sciences sector has been booming even as firms in many other industries are struggling to stay in business. Goodwin’s David Mardle is upbeat about the sector’s ongoing prospects – although M&A deals are currently proving tricky to complete.
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.